The PulmoLife is quickly
programmed according to height, gender and age. A disposable mouthpiece is
supplied After blowing into it, PulmoLife displays
the patients’ FEV1 (2.78 as illustrated) and FEV1% predicted (72% as illustrated).
The percentage of the result against predicted values
helps determine the level of severity of respiratory impairment.
The PulmoLife then uses
these results to calculate and display an optional Lung Age estimation – but for older patients FEV1% is more
use. Decline in lung function in susceptible smokers is twice that of
non-smokers, on average.
Health New Zealand Ltd took delivery of this device in
The best of three technically- satisfactory readings is